^
TruSight Oncology Comprehensive (EU), the first CE-marked IVD test kit for comprehensive genomic profiling based on DNA and RNA that consolidates multiple iterative tests into one. Using a single test assessing hundreds of current and emerging biomarkers, you can now access a clinically-relevant report with the actionable answers to help redefine the journey for cancer patients.
Cancer:
Breast Cancer, CNS Tumor, Colorectal Cancer, Lung Cancer, Melanoma, Ovarian Cancer, Prostate Cancer, Solid Tumor, Thyroid Gland Carcinoma, Uterine Cancer
Gene:
ALK (Anaplastic lymphoma kinase), APC (APC Regulator Of WNT Signaling Pathway), ATM (ATM serine/threonine kinase), ATRX (ATRX Chromatin Remodeler), BARD1 (BRCA1 Associated RING Domain 1), BCOR (BCL6 Corepressor)
See More ...
Drug:
Vitrakvi (larotrectinib)
Method:
Next-Generation Sequencing (NGS)
Approvals
Date
Cancer
Gene
Drug
By
03/15/22
CE